Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial

Published:2021-06 Issue:6 Volume:9 Page:585-592
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

de Gooijer Cornedine J,van der Noort Vincent,Stigt Jos A,Baas Paul,Biesma Bonne,Cornelissen Robin,van Walree Nico,van Heemst Robbert C,Soud Magdolen Youssef-El,Groen Harry J M,den Brekel Agnes J Staal-van,Buikhuisen Wieneke A,Bootsma Gerben P,Dammeijer Floris,van Tinteren Harm,Lalezari Ferry,Aerts Joachim G,Burgers Jacobus A

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Baas;Ann Oncol,2015

2. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England;Damhuis;Lung Cancer,2015

3. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

4. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016

5. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study;Ciuleanu;Lancet,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma;Heliyon;2024-08

2. Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study;The Lancet Oncology;2024-07

3. Targeted Therapy in Mesotheliomas: Uphill All the Way;Cancers;2024-05-22

4. Patient with recurrent paratesticular malignant mesothelioma and multiple primary neoplasms;Journal of Men's Health;2024

5. Small heat shock proteins as modulators of cell death in Plasmodium falciparum parasites and its human host;Frontiers in Cell Death;2023-11-29